Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. E

@article{Bouffioux1995IntravesicalAC,
  title={Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. E},
  author={Christian Bouffioux and K. H. Kurth and Aldo Bono and Wim Oosterlinck and Claudia Kruger and Martine De Pauw and Richard Sylvester},
  journal={The Journal of urology},
  year={1995},
  volume={153 3 Pt 2},
  pages={934-41}
}
The European Organization for Research and Treatment of Cancer genitourinary group has completed 2 parallel prospective randomized studies, one with 30 mg. mitomycin C and the other with 50 mg. doxorubicin as adjuvant intravesical treatment after transurethral resection of superficial transitional cell bladder carcinoma. These studies were designed to compare early (the day of resection) versus delayed (between 7 and 15 days after resection) instillations and short-term (6 months) versus long… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 55 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Maintenance BCG immunotherapy of superficial bladder cancer: a randomized prospective Southwest Oncology Group study

  • D. L. Lamm, E. D. Crawford, +12 authors C. A. Coltman
  • J. Urol.,
  • 1992

Comparison of different schedules of cyto­ static intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multi­ center study with 419 patients

  • H. Huland, G. Klöppel, +7 authors E. Huland
  • J. Urol.,
  • 1990

Quelle chimiothérapie pour quelle tumeur de vessie ?

  • C. Bouffioux, L. Denis, K. H. Kurth, M. De Pauw
  • J . d ’ Urol .
  • 1988

and Members of the Registry for Urinary Tract Tumors , Rheinisch Westfalische Technische Hochschulte , Aachen : Natural history and treatment of low and high risk superficial bladder tumors

  • H. Rübben, W. Lutzeyer, N. Fischer, F. Deutz, W. Lagrange, G. Giani
  • J . Urol .
  • 1988

Similar Papers

Loading similar papers…